v3.26.1
Share-based payments - Summary of Employee Share Options (Detail)
6 Months Ended
Jun. 30, 2026
shares
Warrants
$ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Weighted average exercise price, Outstanding at January 1, $ 2.97
SARs forfeited 0
SARs exercised 1.13
SARs expired 0
Weighted average exercise price, Outstanding at June 30, 3.02
SARs exercisable $ 3.02
Number of share options, outstanding at January 1, | Warrants 457,715
SARs forfeited | Warrants 0
SARs exercised | Warrants 11,480
SARs expired | Warrants 0
Number of share options, outstanding at June 30, | Warrants 446,235
SARs exercisable | Warrants 446,235
Weighted average remaining contract life (years) 1 year 6 months 3 days
Additional Grants Under 2020, 2022, 2024 and 2025 Equity Plan [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Weighted average exercise price, Outstanding at January 1, $ 9.35
SARs forfeited 7.77
SARs exercised 6.78
SARs expired 11.12
Weighted average exercise price, Outstanding at June 30, 9.38
SARs exercisable $ 9.73
Number of share options, outstanding at January 1, | Warrants 11,889,848
SARs forfeited | Warrants 131,258
SARs exercised | Warrants 107,065
SARs expired | Warrants 13,987
Number of share options, outstanding at June 30, | Warrants 15,305,938
SARs exercisable | Warrants 8,264,215
Weighted average remaining contract life (years) 7 years 6 months 10 days
Additional Grants Under 2020, 2022, 2024 and 2025 Equity Plan [Member] | Granted On March 2021 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
SARs granted $ 9.35
SARs granted | Warrants 3,668,400
Performance Based Options [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Weighted average exercise price, Outstanding at January 1, $ 10.1
SARs forfeited 0
Weighted average exercise price, Outstanding at June 30, 10.1
SARs exercisable $ 10.09
Number of share options, outstanding at January 1, | shares 3,668,000
SARs granted | shares 0
SARs forfeited | shares 0
Number of share options, outstanding at June 30, | shares 3,668,000
SARs exercisable | shares 1,215,378
Weighted average remaining contract life (years) 4 years 1 month 6 days
Performance Based Options [Member] | Granted On February 2024 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
SARs granted $ 0
SARs granted | shares 0
Restricted Stock Units  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Weighted average exercise price, Outstanding at January 1, $ 0
Weighted average exercise price, Outstanding at June 30, $ 9.43
Number of share options, outstanding at January 1, | shares 0
Number of share options, outstanding at June 30, | shares 1,233,080
Weighted average remaining contract life (years) 3 years 6 months 29 days
Restricted Stock Units | Granted On February 2024 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
SARs granted $ 9.43
SARs granted | shares 1,233,080
Matching Stock Options [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Weighted average exercise price, Outstanding at January 1, $ 10
SARs forfeited 0
SARs exercised 0
SARs expired 10
Weighted average exercise price, Outstanding at June 30, 10
SARs exercisable $ 10
Number of share options, outstanding at January 1, | Warrants 1,290,682
SARs forfeited | Warrants 0
SARs exercised | Warrants 0
SARs expired | Warrants 140
Number of share options, outstanding at June 30, | Warrants 1,290,542
SARs exercisable | Warrants 1,290,542
Weighted average remaining contract life (years) 4 years